Drug firm Lupin on Friday said it has launched its generic Hydrocortisone Valerate cream USP, used for treatment of inflammation and itching of skin, in the US market.
The company has launched Hydrocortisone Valerate cream USP, 0.2 per cent, having received approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a statement.
The product is the generic version of Sun Pharmaceutical Industries Inc's Westcort cream in the same strength, it added.
According to IQVIA MAT September 2019 data, Hydrocortisone Valerate Cream USP, 0.2 per cent had annual sales of around USD 11.5 million in the US, Lupin said.
The product is "indicated for the relief of the Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients," it added.
Shares of Lupin Ltd closed at Rs 773.30 on BSE, up 0.33 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app